Robust Optimal Scheduling of Combined Chemo- and Immunotherapy: Considerations on Chemotherapy Detrimental Effects

Kaouther Moussa, Mirko Fiacchini, Mazen Alamir

Open source

DOI
10.23919/acc45564.2020.9147869
Published
2020-07
Container
2020 American Control Conference (ACC)
Publisher
IEEE
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.23919/acc45564.2020.9147869,
  title = {Robust Optimal Scheduling of Combined Chemo- and Immunotherapy: Considerations on Chemotherapy Detrimental Effects},
  author = {Kaouther Moussa and Mirko Fiacchini and Mazen Alamir},
  year = {2020},
  journal = {2020 American Control Conference (ACC)},
  doi = {10.23919/acc45564.2020.9147869},
  url = {https://doi.org/10.23919/acc45564.2020.9147869}
}

RIS

TY  - JOUR
TI  - Robust Optimal Scheduling of Combined Chemo- and Immunotherapy: Considerations on Chemotherapy Detrimental Effects
AU  - Kaouther Moussa
AU  - Mirko Fiacchini
AU  - Mazen Alamir
PY  - 2020
JO  - 2020 American Control Conference (ACC)
DO  - 10.23919/acc45564.2020.9147869
UR  - https://doi.org/10.23919/acc45564.2020.9147869
ER  - 

APA

Moussa, K., Fiacchini, M., & Alamir, M. (2020). Robust Optimal Scheduling of Combined Chemo- and Immunotherapy: Considerations on Chemotherapy Detrimental Effects. 2020 American Control Conference (ACC). https://doi.org/10.23919/acc45564.2020.9147869

Source records